Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methazolamide |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethoxyzolamide |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flumethiazide (substance) |
Is a |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetazolamide (substance) |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dorzolamide (substance) |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbonic acid anhydrase inhibitor poisoning NOS |
Causative agent (attribute) |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbonic anhydrase inhibitor adverse reaction (disorder) |
Causative agent (attribute) |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbonic anhydrase inhibitor allergy |
Causative agent (attribute) |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbonic acid anhydrase inhibitor overdose |
Causative agent (attribute) |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carbonic anhydrase inhibitor product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brinzolamide (substance) |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diclofenamide |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetazolamide - chemical |
Is a |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by carbonic acid anhydrase inhibitor |
Causative agent (attribute) |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing carbonic anhydrase inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction to carbonic acid anhydrase inhibitor NOS |
Causative agent (attribute) |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
[X]Carbonic-anhydrase inhibitors causing adverse effects in therapeutic use |
Causative agent (attribute) |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbonic anhydrase inhibitor allergy |
Causative agent (attribute) |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diclofenamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dorzolamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing brinzolamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dichlorphenamide adverse reaction |
Causative agent (attribute) |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to diclofenamide |
Causative agent (attribute) |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely dorzolamide (as dorzolamide hydrochloride) 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dorzolamide- and timolol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely brinzolamide 10 milligram/1 milliliter conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dichlorphenamide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dorzolamide hydrochloride |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetazolamide sodium |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polmacoxib |
Is a |
True |
Substance with carbonic anhydrase inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|